Kuma Yuki, Ito Takamichi, Nagae Konosuke, Mizote Yukihiro, Nakahara Takeshi, Uchi Hiroshi, Yamada Yuichi, Okura Masae, Oda Yoshinao, Yamashita Toshiharu, Furue Masutaka
Department of Dermatology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Department of Anatomic Pathology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Case Rep Dermatol. 2015 Jul 25;7(2):178-82. doi: 10.1159/000438504. eCollection 2015 May-Aug.
Increasing evidence has suggested that human papillomaviruses (HPVs) are linked to a large subset of numerous malignant tumors, including mucosal squamous cell carcinoma (SCC); however, its involvement in cutaneous SCC has not fully been elucidated. Cutaneous SCC is the second most common type of skin cancer and is increasing in frequency every year. Since we have no satisfactory treatment for advanced SCC, it is important to provide a definitive diagnosis and appropriate therapeutic intervention at an early stage. Here, we present two cases of SCC arising in immunosuppressed patients. In these cases, we suspected the association between SCC and HPV infection histopathologically and succeeded in proving the presence of high-risk type HPV by PCR analysis (HPV 14 in case 1 and HPV 23 and 38 in case 2). Although it is unclear whether HPV actually induced SCC in our cases, our cases showed rapid progression comparing to typical courses of actinic keratosis (AK)/SCC. SCC and AK are common diseases; in daily practice, dermatologists examine many patients with immunosuppression of various causes. We should apply increased oncological vigilance to these patients to prevent an aggressive course of SCC/AK.
越来越多的证据表明,人乳头瘤病毒(HPV)与众多恶性肿瘤的很大一部分相关,包括黏膜鳞状细胞癌(SCC);然而,其在皮肤鳞状细胞癌中的作用尚未完全阐明。皮肤鳞状细胞癌是第二常见的皮肤癌类型,且发病率逐年上升。由于我们对晚期鳞状细胞癌没有令人满意的治疗方法,因此在早期提供明确的诊断和适当的治疗干预非常重要。在此,我们报告两例免疫抑制患者发生的鳞状细胞癌病例。在这些病例中,我们从组织病理学上怀疑鳞状细胞癌与HPV感染之间存在关联,并通过聚合酶链反应(PCR)分析成功证实了高危型HPV的存在(病例1为HPV 14,病例2为HPV 23和38)。虽然在我们的病例中尚不清楚HPV是否真的诱发了鳞状细胞癌,但与典型的光化性角化病(AK)/鳞状细胞癌病程相比,我们的病例显示出快速进展。鳞状细胞癌和光化性角化病是常见疾病;在日常实践中,皮肤科医生会检查许多因各种原因导致免疫抑制的患者。我们应该对这些患者提高肿瘤学警惕性,以预防鳞状细胞癌/光化性角化病的侵袭性病程。